These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21509189)

  • 1. Rethinking cycad metabolite research.
    Snyder LR; Marler TE
    Commun Integr Biol; 2011 Jan; 4(1):86-8. PubMed ID: 21509189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycas micronesica (Cycadales) plants devoid of endophytic cyanobacteria increase in beta-methylamino-L-alanine.
    Marler TE; Snyder LR; Shaw CA
    Toxicon; 2010 Sep; 56(4):563-8. PubMed ID: 20570592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
    Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
    J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
    Brownson DM; Mabry TJ; Leslie SW
    J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae.
    Duncan MW; Kopin IJ; Crowley JS; Jones SM; Markey SP
    J Anal Toxicol; 1989; 13(4):suppl A-G. PubMed ID: 2490746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Duncan MW; Steele JC; Kopin IJ; Markey SP
    Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of ß-N-methylamino-L-alanine in cyanobacteria and aquatic organisms from waters of Northern Poland; BMAA toxicity studies.
    Błaszczyk A; Siedlecka-Kroplewska K; Woźniak M; Mazur-Marzec H
    Toxicon; 2021 Apr; 194():90-97. PubMed ID: 33610631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
    Banack SA; Caller TA; Stommel EW
    Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
    Banack SA; Cox PA
    Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycad β-N-methylamino-L-alanine (BMAA), methylazoxymethanol, genotoxicity, and neurodegeneration.
    Spencer PS; Palmer VS; Kisby GE
    Toxicon; 2018 Dec; 155():49-50. PubMed ID: 30316979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Methylamino-L-alanine-induced protein aggregation in vitro and protection by L-serine.
    Quinn AW; Phillips CR; Violi JP; Steele JR; Johnson MS; Westerhausen MT; Rodgers KJ
    Amino Acids; 2021 Sep; 53(9):1351-1359. PubMed ID: 34283312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
    Kisby GE; Ellison M; Spencer PS
    Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
    Stommel EW; Field NC; Caller TA
    Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of the neurotoxin BMAA by a marine cyanobacterium.
    Banack SA; Johnson HE; Cheng R; Cox PA
    Mar Drugs; 2007 Dec; 5(4):180-96. PubMed ID: 18463731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.